CBLL:NASDAQ, CeriBell, Inc.

CBLL stock overview

CeriBell, Inc. (CBLL:NASDAQ) closed at $26.42 on November 16, 2026, up 1.07% on the day. The stock trades 8.5% below its 52-week high of $28.89 and 108.9% above its 52-week low of $12.65. Over the past year, it gained 100.2%. CeriBell, Inc. is part of the Health Care sector.

Key figures

Price
$26.42
Day change
+1.07%
Volume
770,439
Average volume
443,960
Market cap
1B+
52-week range
$12.65 – $28.89
50-day average
$25.52
200-day average
$21.04

Price action over the past year

In 252 trading sessions since November 14, 2025, CBLL closed higher on 129 days (51%). Its best day was November 21, 2025 (+11.88%) and its worst was May 12, 2026 (-16.50%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CBLL news

About CeriBell, Inc.

CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.

Similar stocks

Find more stocks like CBLL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.